Tyra Biosciences Files 8-K on Security Holder Vote Matters
Ticker: TYRA · Form: 8-K · Filed: May 29, 2025 · CIK: 1863127
| Field | Detail |
|---|---|
| Company | Tyra Biosciences, Inc. (TYRA) |
| Form Type | 8-K |
| Filed Date | May 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: TYRA
TL;DR
TYRA filed an 8-K for a shareholder vote. Details TBD.
AI Summary
Tyra Biosciences, Inc. filed an 8-K on May 29, 2025, to report on the submission of matters to a vote of its security holders. The filing does not disclose specific details about the matters to be voted on or any outcomes.
Why It Matters
This filing indicates that Tyra Biosciences is seeking or has sought approval from its shareholders on certain corporate actions, which could impact the company's governance or strategic direction.
Risk Assessment
Risk Level: low — The filing is procedural and does not contain new financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- Tyra Biosciences, Inc. (company) — Registrant
- May 29, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 2656 State Street Carlsbad, California 92008 (address) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Tyra Biosciences' security holders?
The filing states that matters were submitted to a vote of security holders, but it does not specify what those matters are.
When did the earliest event reported in this 8-K occur?
The earliest event reported in this 8-K occurred on May 29, 2025.
What is Tyra Biosciences, Inc.'s principal executive office address?
Tyra Biosciences, Inc.'s principal executive office is located at 2656 State Street, Carlsbad, California 92008.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the Commission File Number for Tyra Biosciences, Inc.?
The Commission File Number for Tyra Biosciences, Inc. is 001-40800.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 29, 2025 regarding Tyra Biosciences, Inc. (TYRA).